The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

David van Duin (Lead / Corresponding author), Gavin Barlow, Dilip Nathwani

    Research output: Contribution to journalComment/debatepeer-review

    Abstract

    The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.

    Original languageEnglish
    Article numberdlaa053
    Number of pages2
    JournalJAC-antimicrobial resistance
    Volume2
    Issue number3
    Early online date17 Jul 2020
    DOIs
    Publication statusPublished - Sep 2020

    Keywords

    • antibiotics
    • drug resistance
    • microbial
    • travel
    • infections
    • morbidity
    • mortality
    • public health medicine
    • antimicrobials
    • pandemics
    • sars-cov-2
    • covid-19
    • coronavirus pandemic
    • physical distancing

    Fingerprint

    Dive into the research topics of 'The impact of the COVID-19 pandemic on antimicrobial resistance: a debate'. Together they form a unique fingerprint.

    Cite this